Correlation Between NewAmsterdam Pharma and OncoVista Innovative
Can any of the company-specific risk be diversified away by investing in both NewAmsterdam Pharma and OncoVista Innovative at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NewAmsterdam Pharma and OncoVista Innovative into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NewAmsterdam Pharma and OncoVista Innovative Therapies, you can compare the effects of market volatilities on NewAmsterdam Pharma and OncoVista Innovative and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NewAmsterdam Pharma with a short position of OncoVista Innovative. Check out your portfolio center. Please also check ongoing floating volatility patterns of NewAmsterdam Pharma and OncoVista Innovative.
Diversification Opportunities for NewAmsterdam Pharma and OncoVista Innovative
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between NewAmsterdam and OncoVista is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding NewAmsterdam Pharma and OncoVista Innovative Therapies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on OncoVista Innovative and NewAmsterdam Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NewAmsterdam Pharma are associated (or correlated) with OncoVista Innovative. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of OncoVista Innovative has no effect on the direction of NewAmsterdam Pharma i.e., NewAmsterdam Pharma and OncoVista Innovative go up and down completely randomly.
Pair Corralation between NewAmsterdam Pharma and OncoVista Innovative
If you would invest 1,913 in NewAmsterdam Pharma on August 28, 2024 and sell it today you would earn a total of 192.00 from holding NewAmsterdam Pharma or generate 10.04% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
NewAmsterdam Pharma vs. OncoVista Innovative Therapies
Performance |
| Timeline |
| NewAmsterdam Pharma |
| OncoVista Innovative |
NewAmsterdam Pharma and OncoVista Innovative Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with NewAmsterdam Pharma and OncoVista Innovative
The main advantage of trading using opposite NewAmsterdam Pharma and OncoVista Innovative positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NewAmsterdam Pharma position performs unexpectedly, OncoVista Innovative can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OncoVista Innovative will offset losses from the drop in OncoVista Innovative's long position.| NewAmsterdam Pharma vs. Monte Rosa Therapeutics | NewAmsterdam Pharma vs. Inventiva Sa | NewAmsterdam Pharma vs. Cullinan Oncology LLC | NewAmsterdam Pharma vs. Compass Therapeutics |
| OncoVista Innovative vs. Rezolute | OncoVista Innovative vs. Tempest Therapeutics | OncoVista Innovative vs. Forte Biosciences | OncoVista Innovative vs. Dyadic International |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Other Complementary Tools
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |